Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More engineering services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Technology Development Program

U.S. National Institutes of Health·United States of America

Technology Development Program

Closes 2/4/2028$500k – $3MGrants Notice
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is forecasting a Technology Development Program to fund innovative technology research projects that move from proof‑of‑concept to prototype. The program emphasizes novel technological advances that will accelerate future biomedical research, explicitly excluding projects that focus on testing biological hypotheses or biomedical aims. Eligible applicants include a broad range of public, private, nonprofit, tribal, and government entities, with a focus on entities capable of high‑risk, high‑reward technology development. Funding is provided as a grant, with no cost‑sharing required, and the anticipated award period begins December 1 2028. The forecast includes estimated dates for synopsis posting (December 5 2027), application response (February 5 2028), award (December 1 2028), and project start (December 1 2028). No ceiling or floor amounts are disclosed, and the solicitation does not require a pre‑bid meeting or site visit. • Supports technology research from proof‑of‑concept through prototype development. • Prioritizes innovation over feasibility; no biological hypothesis testing allowed. • Open to a wide variety of applicants (universities, for‑profit firms, NGOs, tribal governments, etc.). • Grant‑type funding with no cost‑sharing requirement. • Forecast dates: posting 9/16/2026, synopsis 12/5/2027, application due 2/5/2028, award 12/1/2028, project start 12/1/2028. • No pre‑bid meeting or mandatory site visit. • Contact via e‑mail: [email protected].

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

NIGMS Technology Development

[email protected]

Key dates

Opened
9/16/2026
Closes
2/4/2028
Projected award
12/1/2028

Last updated

Details

Type
Grants Notice
Industry
Engineering Services
NAICS
541715
Solicitation №
PAR-29-005

Budget estimate

$500,000 – $3,000,000

The solicitation does not list an award ceiling or floor, but NIH technology‑development grants typically range from a few hundred thousand dollars for early‑stage prototypes up to several million dollars for more advanced projects. Considering the “proof‑of‑concept through prototype” scope and the broad eligibility, a reasonable estimate is $500,000 to $3,000,000 per award, depending on project complexity, team size, and deliverables.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 87%

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

86% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

85% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

85% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

85% match

Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

Closes 1/29/2029Opened 9/2/2025

U.S. National Institutes of Health·United States of America

85% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

85% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. National Institutes of Health·United States of America

84% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 1/11/2022

U.S. National Institutes of Health·United States of America

84% match

NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)

Closes 5/7/2029Opened 9/15/2025

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

84% match

Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences

Closes 5/24/2027Opened 9/22/2026

U.S. National Institutes of Health·United States of America

84% match

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Closes 11/10/2026Opened 6/25/2026

U.S. National Institutes of Health·United States of America

84% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. National Institutes of Health·United States of America

84% match

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

84% match

Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)

Closes 1/26/2029Opened 8/27/2025

U.S. National Institutes of Health·United States of America

84% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

84% match

R3PEATS Grassroots Rigor Projects: Individual Metascience and Individual Laboratory Capacity-Building (RP1)

Closes 9/30/2027Opened 9/11/2026

U.S. National Institutes of Health·United States of America

84% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. National Institutes of Health·United States of America

84% match

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

Closes 5/30/2029Opened 11/19/2025

U.S. National Institutes of Health·United States of America

84% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

84% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

84% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

83% match

Limited Competition: Tribal Undergraduate and Graduate Research Training and Leadership Experiences (TURTLE) Program

Closes 1/24/2028Opened 9/14/2026

U.S. National Institutes of Health·United States of America

83% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

83% match

National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Closes 1/24/2027Opened 6/9/2026